Presidio wins FDA IDE for ultra-low frequency neuromod
June 12, 2025
Presidio Medical announced today that it received FDA investigational device exemption (IDE) for its ultra-low frequency (ULF) neuromodulation platform.
Presidio Medical announced today that it received FDA investigational device exemption (IDE) for its ultra-low frequency (ULF) neuromodulation platform.
Scientists with the Fralin Biomedical Research Institute at VTC have created an engineered model of the supportive tissue found within a lymph node to study human health.
New research from SUNY Polytechnic Institute introduces an innovative, eco-friendly method to enhance the performance and longevity of titanium-based dental implants, focusing on improving the biocompatibility and mechanical resilience of Ti-6Al-4V alloy implants using hydroxyapatite (HA) coatings derived from biowaste.
A study published in Current Biology demonstrates that scientists can identify individuals based solely on their breathing patterns with 96.8% accuracy. These nasal respiratory “fingerprints” also offer insights into physical and mental health.
Label Update Now Includes Data from Pivotal TAILORED-AF Trial, Strengthening Clinical Validation for AI-Guided AF Ablation
New Clinical Data Shows Significant Delay in Disease Progression and Cognitive Decline in Alzheimer’s Patients Using Cognito’s Wearable Neurotech
New leadership and AI-driven technology aim to revolutionize assessment and care for brain-related conditions
Neurent Medical announced that it received FDA 510(k) clearance for its next-generation Neuromark system for chronic rhinitis.
Accelus today announced it received FDA 510(k) clearance for its FlareHawk Interbody Fusion System to be safely scanned under certain MRI conditions
SARASOTA, Fla. and HUNTSVILLE, Ala., June 11, 2025 /PRNewswire/ — World Precision Instruments (WPI), a global leader in transepithelial electrical resistance (TEER) instrumentation, and SynVivo Inc., a pioneer in Organ-on-a-Chip (OOC) technology, today announced the commercial launch of a next-generation multiplexed TEER-on-a-Chip platform—a breakthrough solution enabling real-time, high-throughput measurement of barrier integrity in advanced Organ-on-a-Chip models.